Hall Laurie J Trustee Fibrogen Inc Transaction History

Hall Laurie J Trustee

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$13.27 - $17.73 $398 - $531	-30 Reduced 33.33%	60 $1,000
Q3 2022 Oct 11, 2022	SELL	$11.4 - $14.6 $456 - $584	-40 Reduced 30.77%	90 $1,000
Q3 2021 Oct 04, 2021	SELL	$10.18 - $26.64 $814 - $2,131	-80 Reduced 38.1%	130 $1,000
Q3 2020 Oct 09, 2020	BUY	$40.47 - $45.5 $2,428 - $2,730	60 Added 40.0%	210 $9,000
Q4 2019 Feb 12, 2020	BUY	$34.58 - $48.06 $1,037 - $1,441	30 Added 25.0%	150 $6,000
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $759 - $1,203	-20 Reduced 14.29%	120 $7,000
Q4 2017 Jan 30, 2018	SELL	$41.95 - $60.1 $3,356 - $4,808	-80 Reduced 36.36%	140 $7,000
Q2 2017 Aug 22, 2017	BUY	N/A	220	220 $0

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.